TriangleNCT02566265 · OUTCOME
Number of Participants With Treatment Failure by Primary Endpoint
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 1 year
What was measured
Any documented flu infection during the 2015-2016 flu season or evidence of disease progression.
Groups in this outcome
Fluzone High Dose Vaccine Then Fluzone High Dose Booster
Fluzone High dose vaccine administered at Day 0. Fluzone High dose vaccine administered as a booster after 30 days from the initial vaccine. Fluzone High Dose Vaccine
Standard of Care
Fluzone High-Dose if age greater than or equal to 65 or Standard dose influenza vaccine if age less than 65 at day 0. Placebo administered 30 days after the initial vaccine. Standard of care/Placebo
| Group | Source count |
|---|---|
| Fluzone High Dose Vaccine Then Fluzone High Dose Booster | 81 |
| Standard of Care | 41 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Fluzone High Dose Vaccine Then Fluzone High Dose Booster | 26 | Not reported | Not reported | Not reported | Not reported |
| Standard of Care | 13 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 26
- group Id
- OG001
- value
- 13
- denoms
- counts
- group Id
- OG000
- value
- 81
- group Id
- OG001
- value
- 41
- units
- Participants
- description
- Any documented flu infection during the 2015-2016 flu season or evidence of disease progression.
- groups
- description
- Fluzone High dose vaccine administered at Day 0. Fluzone High dose vaccine administered as a booster after 30 days from the initial vaccine. Fluzone High Dose Vaccine
- id
- OG000
- title
- Fluzone High Dose Vaccine Then Fluzone High Dose Booster
- description
- Fluzone High-Dose if age greater than or equal to 65 or Standard dose influenza vaccine if age less than 65 at day 0. Placebo administered 30 days after the initial vaccine. Standard of care/Placebo
- id
- OG001
- title
- Standard of Care
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- 1 year
- title
- Number of Participants With Treatment Failure by Primary Endpoint
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice